基本信息
浏览量:0
职业迁徙
个人简介
Dr. Lieberman’s research has been supported by grants from the National Institutes of Health and the NARSAD, Stanley, and Mental Illness Foundations and has focused on the neurobiology, pharmacology and treatment of schizophrenia and related psychotic disorders. In this context, his work has advanced our understanding of the natural history and pathophysiology of schizophrenia and the pharmacology and clinical effectiveness of antipsychotic drugs. In terms of the latter, he served as Principal Investigator of the Clinical Antipsychotic Trials of Intervention Effectiveness Research Program (CATIE), sponsored by the NIMH.
研究兴趣
论文共 1052 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hannah M. Hesson,Eileen A. Shea,Paul S. Appelbaum,Gabriella Dishy, Carol Cohen-Romano,Leda Kennedy, Melissa Bornico,Kathryn Lee,Tyler Pia,Faizan Syed,Alexandra Villalobos,Jeffrey A. Lieberman,
VIOLENCE AND VICTIMSno. 1 (2023): 15-24
Schizophrenia research (2023): 234-235
引用0浏览0WOS引用
0
0
The pharmacogenomics journalno. 5 (2023): 119-126
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn